Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation
Conditions: Hematopoietic System--Cancer Interventions: Behavioral: Control Group (Active Comparator); Behavioral: Intervention Group Sponsors: Alejandro Lucia; Hospital Infantil Universitario Ni ño Jesús, Madrid, Spain; Hospital General Universitario Gregorio Marañon; Hospital Universitario La Paz; Hospital Universitario 12 de Octubre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation
Conditions: Allogeneic Stem Cell Transplantation Interventions: Drug: ASTX727; Drug: Donor Lymphocyte Infusion Sponsors: M.D. Anderson Cancer Center; Astex Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Homogenized Prescription Enterobacteria Capsule in Patients With IBS-D
Conditions: Irritable Bowel Syndrome With Diarrhea; Fecal Microbiota Transplantation Interventions: Drug: Homogenized Prescription Enterobacteria Capsule; Drug: Placebo Sponsors: Shenzhen Hospital of Southern Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
PTCy and ATG for MSD and MUD Transplants
Conditions: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Hodgkin Lymphoma; Non-hodgkin Lymphoma Interventions: Drug: ATG 5.0; Drug: Cyclophosphamide injection; Drug: ATG 2.5 ±1.5 Sponsors: Instituto Nacional de Cancer, Brazil Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Bioenergy, Depression, Anxiety and Stress After Liver Transplantation
Conditions: Mental Health Issue Interventions: Behavioral: Bioenergy application Sponsors: Istanbul Ayd ın University Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial
DiscussionBased on preclinical and early pilot clinical evidence, we want to test the novel concept of temporary (lymph)angioregressive pretreatment of high-risk eyes by CXL to promote subsequent corneal graft survival. So far, there is no evidence-based approach to reliably improve graft survival in the high-risk corneal transplantation setting available in clinical routine. If successful, this approach will be the first to promote graft survival in high-risk transplants. It will significantly improve vision and quality of life in patients suffering from corneal blindness.Trial registrationClinicalTrials.gov NCT05870566. ...
Source: Trials - March 6, 2024 Category: Research Source Type: clinical trials
Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - < BELAFENDO >
Conditions: Kidney Diseases Interventions: Drug: Belatacept; Drug: anticalcineurins Sponsors: University Hospital, Rouen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)
Conditions: Kidney Transplant Rejection Interventions: Drug: Conversion to Belatacep; Drug: Standard of care treatment (SOC regimen) with Tacrolimus Sponsors: University Hospital, Rouen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Factors Associated With Posttransplant Cardiac Outcomes
Conditions: Cardiovascular Diseases; Liver Transplantation Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
Conditions: Autism Spectrum Disorder; Gastrointestinal Diseases; Healthy Interventions: Procedure: Fecal microbiota transplantation Sponsors: Chang Gung Memorial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Long-term Outcomes of Living Donor Liver Transplantations With Anti-HBc (+) Grafts in Pediatric Patients
Conditions: Living Donor Liver Transplantations With Anti-HBc (+) Grafts Sponsors: Chang Gung Memorial Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Outcome Study of Conventional Steroids vs. Steroids Combined With Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.
Conditions: Immune Thrombocytopenia Purpura Interventions: Drug: Mycophenolate Mofetil (MMF) Treatment Sponsors: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation
Conditions: Renal Transplant; Kidney Transplant Interventions: Drug: Sodium Thiosulfate Sponsors: Alp Sener Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Spatial Transcriptomics in Kidney Transplantation
Conditions: Transplant Complication; Kidney Injury Interventions: Other: Non interventional Sponsors: Western Sydney Local Health District Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome Interventions: Biological: Actinium Ac 225-DOTA-Daratumumab; Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Biological: Daratumumab; Procedure: Echocardiography; Drug: Fludarabine; Procedure: Hematopoietic Cell Transplantation; Biological: Indium In 111-DOTA-Daratumumab; Drug: Melphalan; Procedure: Multigated Acquisition Scan; Procedure: Radionuclide Imaging; Procedure: Single Photon Emission Computed Tomography; Drug: Sirolimus; Drug: Tacrolimus; R...
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
